| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |